Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study
RecruitingOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
June 3, 2025
Primary Completion Date
June 30, 2030
Study Completion Date
June 30, 2030
Conditions
Lung Cancer (NSCLC)
Trial Locations (1)
37000
RECRUITING
university hospital, Tours, Tours
All Listed Sponsors
lead
University Hospital, Tours
OTHER
NCT07004868 - Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study | Biotech Hunter | Biotech Hunter